Purtscher retinopathy as the initial sign of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Arch Ophthalmol 2001; 119 (9): 1388–1389. Article CAS Google Scholar ...

Purtscher’s retinopathy is rare and most commonly seen after trauma, acute pancreatitis, crush-type injury, long-bone fracture, orthopedic surgery and childbirth. 2 Acute retinal signs often persist ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Oral APX3330 showed clinically meaningful response compared with placebo in slowing progression of diabetic retinopathy in the phase 2 ZETA-1 trial. Ocuphire Pharma’s study results were ...

Diabetic retinopathy is the most common diabetic eye disease and the leading cause of vision loss and blindness in American working age adults, which affects nearly 10 million people in the US 1.

Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with diabetic retinopathy ("DR").

In patients with proliferative diabetic retinopathy (PDR), treatment with panretinal photocoagulation (PRP) followed by anti–vascular endothelial growth factor (anti-VEGF) appears to increase ...